Fresh From the Bench: Latest Federal Circuit Court Cases
Contributed by Schwabe Williamson & Wyatt. Originally published on Patexia; republished here as part of the LexDana archive.
CASE OF THE WEEK
CenTrak, Inc. v. Sonitor Technologies, Inc., Appeal No. 2017-2510 (Fed. Cir. Feb. 14, 2019)
In this appeal from the United States District Court for the District of Delaware, the Federal Circuit reversed and remanded an order granting Sonitor’s motions for summary judgment of non-infringement and invalidity, based on lack of written description, of U.S. Patent No. 8,604,909 (“the ’909 patent”).
The ’909 patent relates to systems for real-time location, which allow users to locate and identify portable devices in a facility, such as a hospital, by using a base station that communicates with the portable devices. While the claims at issue require “ultrasonic” components for the communication, the majority of the specification—in fact, all but two sentences—discusses infrared or radio frequency components.
In granting Sonitor’s motion for summary judgment of invalidity, the district court focused on those two sentences, finding that while the specification “contemplated” ultrasound, it was not sufficient to meet the written description requirement. The Federal Circuit disagreed, finding that genuine issues of material fact remain as to whether the specification adequately disclosed the implementation details for how a portable device can communicate with the corresponding base station using ultrasonic technology.
Written by: Scott D. Eads and Nika Aldrich, Schwabe Williamson & Wyatt
Contributor: Erin Forbes
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…